In leukemia and lung cancer cell lines overexpression of ALDH1A2a and ALDH2 increased cell proliferation and resistance to 4-hydroperoxicyclophosphamide and doxorubicin indicating a role for the ALDH isozymes in drug resistance [6]. Here, LDHA is linked to lung cancer.